Concepedia

Author

Miran Šebeštjen

Ljubljana University Medical CentreORCID

Also Known As

M Sebestjen, M ŠEbeštjen, M. Sebestjen, M. S̆ebes̆tjen, M. S̆ebeštjen, M. ŠEBEŠTJEN, M. Šebeštjen, MIRAN SEBESTJEN, Miran SEBESTJEN, Miran Sebestjen

122

Publications

1.2K

Citations

20

H-Index

42

Concepts

All Affiliations

Ljubljana University Medical CentreUniversity of LjubljanaUniversity of MariborStanford UniversityDiabetes Australia
MŠ

About

Miran Šebeštjen is an author at Ljubljana University Medical Centre specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

13

383

2

Public Health

2

2

29

3

Endocrinology

2

2

83

4

Health Sciences

1

1

48

5

Emergency Medicine

1

1

33

Miran Šebeštjen

×

29

Publications

941

Citations

17

H-Index

YearCitations

The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women

Branka Žegura, B. Gužič‐Salobir, Miran Šebeštjen,

Menopause The Journal of The North American Menopause Society

2006

84

Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome

Mojca Jensterle, Miran Šebeštjen, Andrej Janež,

European Journal of Endocrinology

2008

83

Influence of Atorvastatin Treatment on <scp>l</scp> -Arginine Cerebrovascular Reactivity and Flow-Mediated Dilatation in Patients With Lacunar Infarctions

Janja Pretnar Oblak, Mišo Šabović, Miran Šebeštjen,

Stroke

2006

77

Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis

Branka Žegura, Irena Keber, Miran Šebeštjen,

Atherosclerosis

2003

70

Procoagulant State in Heart Failure With Preserved Left Ventricular Ejection Fraction

Borut Jug, Nina Vene, Barbara Salobir,

International Heart Journal

2009

59

Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome

Katica Bajuk Studen, Miran Šebeštjen, Marija Pfeifer,

European Journal of Endocrinology

2010

58

Endothelial function is impaired in patients with primary antiphospholipid syndrome

Monika Štalc, Pavel Poredoš, Polona Peternel,

Thrombosis Research

2005

48

Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure

Borut Jug, Barbara Salobir, Nina Vene,

Heart and Vessels

2009

46

Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors

Irena Keber, Branka Žegura, Saša Simčič,

Thrombosis and Haemostasis

2004

42

Interleukin-6 Correlates with Endothelial Dysfunction in Young Post-Myocardial Infarction Patients

Barbara Eržen, Mišo Šabović, Miran Šebeštjen,

Cardiology

2006

35

Page 1